Anavex Life Sciences Corp. · LSE:0HFR
Anavex Life Sciences Corp. financial statements
Anavex Life Sciences Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research and development | 37.6M | 41.8M | 43.7M | 37.9M | 33.0M | 25.2M | 22.3M | 13.3M | 10.7M | 7.25M |
| Selling, general and administrative | 13.8M | 11.0M | 12.0M | |||||||
| Operating income | -51.4M | -52.9M | -55.8M | -51.0M | -42.0M | -31.1M | ||||
| Depreciation and amortization | 1.25K | |||||||||
| Income before tax | -46.4M | -43.0M | -47.5M | -47.6M | -37.6M | -26.3M | -26.2M | -17.2M | -13.4M | -14.7M |
| Net income | -46.4M | -43.0M | -47.5M | -48.0M | -37.9M | -26.3M | -26.3M | -17.3M | -13.5M | -14.7M |
| Earnings per share, basic | -0.54 | -0.52 | -0.60 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 | -0.33 | -0.42 |
| Earnings per share, diluted | -0.54 | -0.52 | -0.60 | -0.62 | -0.54 | -0.45 | -0.54 | -0.39 | -0.33 | -0.42 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 102.6M | 132.2M | 151.0M | 149.2M | 152.1M | 29.2M | 22.2M | 22.9M | 27.4M | 9.19M |
| Current assets | 25.3M | 26.1M | 27.8M | 9.45M | ||||||
| Total assets | 103.8M | 135.6M | 154.4M | 152.7M | 161.6M | 34.5M | 25.3M | 26.2M | 27.8M | 9.50M |
| Accounts payable | 4.25M | 9.63M | 4.32M | 3.83M | 4.74M | 3.99M | 3.52M | 2.96M | ||
| Current liabilities | 10.8M | 7.31M | 5.04M | 3.88M | 3.58M | 3.19M | ||||
| Total liabilities | 8.95M | 15.3M | 12.5M | 10.2M | 10.8M | 7.31M | 5.04M | 3.58M | 3.19M | |
| Shareholders' equity | 94.9M | 120.3M | 141.9M | 142.5M | 150.8M | 27.2M | 20.3M | 22.3M | 25.9M | 6.31M |
| Shares outstanding | 86.7M | 84.8M | 82.1M | 77.9M | 75.9M | 62.0M | 52.7M | 45.9M | 43.3M | 36.2M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -39.0M | -30.8M | -27.8M | -24.2M | -30.4M | -21.3M | -18.5M | -12.6M | -9.02M | -9.24M |
| Cash from financing | 9.43M | 12.0M | 29.7M | 21.3M | 153.2M | 28.4M | 17.8M | 8.07M | 27.3M | 3.13M |
| Change in cash | -29.6M | -18.8M | 1.87M | -2.95M | 122.9M | 7.06M | -745.0K |